Blogs
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense. A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of...
Two of Moderna’s founders, and one investor, are among 44 new billionaires on the Forbes 400 list this year At least three people with a stake in the coronavirus vaccine race have just made a list of the top 400 richest people in...
A preview of arguments to come After a tedious day of bickering, Victoria Sung appeared like manna from heaven — to tell us that Theranos’ tests sucked. Sung worked at Celgene when it contracted with Theranos. Her testimony was brief and...
CAMBRIDGE, Mass. — At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize...
Science visited Moderna in 2017 for an early look at its innovative RNA-based technology for drugs and vaccines. *Update, 16 November, 9:10 a.m.: Moderna announced today that its experimental mRNA vaccine for COVID-19 achieved 94.5% protective...
Much of the excitement related to digital pathology comes from the ability to rapidly move cases from one place to another. Remote access from home, speedy consultations, rapid review of archival material, and access to cases for clinical...
